Sonoma Biotherapeutics is inventing the future of living therapies for autoimmune disease — safe, effective treatments as unique as each individual patient. Regulatory T cell therapies that harness a patient’s own immune cells, powerful next generation gene editing techniques and advanced manufacturing and quality assurance processes. Sonoma’s mission is to create a best-in-class regulatory T cell therapy that delivers long-lasting, highly efficacious treatments leading to cures across a spectrum of autoimmune and degenerative diseases.
Location: United States, California, South San Francisco
Employees: 51-200
Total raised: $375M
Founded date: 2019
Investors 6
| Date | Name | Website |
| - | T1D Fund | t1dfund.or... |
| - | Octagon Ca... | octagoninv... |
| - | 8VC | 8vc.com |
| - | Timefolio ... | timefolioc... |
| 15.10.2020 | Lifeforce ... | lifeforcec... |
| 07.08.2021 | GV | gv.com |
Funding Rounds 3
| Date | Series | Amount | Investors |
| 04.08.2021 | Series B | $265M | - |
| 30.09.2020 | Series A | $70M | - |
| 06.02.2020 | Series A | $40M | - |
Mentions in press and media 14
| Date | Title | Description | Source |
| 11.04.2023 | Tech Moves: Adaptive Biotechnologies COO departing; Sana add... | Mark Adams. (Adaptive Photo) — Mark Adams is stepping down as chief operating officer of Adaptive B... | geekwire.c... |
| 28.03.2023 | Sonoma Bio inks $75M deal with Regeneron to advance cell the... | Sonoma’s therapies harness regulatory T cells (Tregs), shown here in red interacting with another ty... | geekwire.c... |
| 04.08.2021 | Ally Bridge Portfolio News – Sonoma Biotherapeutics Raises $... | Sonoma Biotherapeutics’ platform and product candidates aim to restore immune system balance through... | ally-bridg... |
| 04.08.2021 | Why the IPO markets aren’t quite the dotcom bubble all over ... | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign ... | fortune.co... |
| 04.08.2021 | Sonoma Biotherapeutics Inks $265M Series B | SOUTH SAN FRANCISCO, CA, Sonoma Biotherapeutics, an immune tolerance company, has announced an ove... | vcnewsdail... |
| 04.08.2021 | Why the IPO markets aren’t quite the dotcom bubble all over ... | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign ... | fortune.co... |
| 04.08.2021 | Sonoma Biotherapeutics : Raises $265 Million in an Oversubsc... | Sonoma Biotherapeutics, an immune tolerance company focused on the development of regulatory T cell ... | marketscre... |
| 30.09.2020 | Sonoma Biotherapeutics : Expands Series A Financing to $70 M... | Sonoma Biotherapeutics, a privately held company developing regulatory T-cell (Treg) therapies for a... | marketscre... |
| 30.09.2020 | Sonoma Biotherapeutics Adds $30M to Series A | SOUTH SAN FRANCISCO, CA, Sonoma Biotherapeutics announced that it has raised an additional $30 mil... | vcnewsdail... |
| 11.02.2020 | T Cell Therapy Company Sonoma Biotherapeutics Raises $40 Mil... | Sonoma Biotherapeutics, a company that is developing regulatory T cell (Treg) therapies for autoimmu... | pulse2.com... |
Show more